Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(2):437-42.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.